Coronavirus (COVID-19) Advocacy
The ADA is lobbied Congress and the administration to protect dental patients and staff who are providing urgent and emergency care during the COVID-19 pandemic. The ADA is also lobbed to help dental practices stay viable during (and following) prolonged periods of reduced hours or closure. Visit ada.org to learn more about the Coronavirus (COVID-19) advocacy efforts.
Oral care considerations for patients using semaglutide, similar medications
Oct 23, 2025
A growing number of popular prescription medications including Ozempic and Wegovy also affect patients’ oral health.
https://adanews.ada.org/ada-news/2025/october/oral-care-considerations-for-patients-using-semaglutide-similar-medications/
